ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

NCAB Working Group Renamed, Adds Karen Antman

December 16, 1994

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002

Guest Opinion: Long Island Study’s Value Now Rests In Its Repository

November 2, 2002